cancer « Science and Enterprise

Implanted Tissue Shown to Produce Thyroid Hormones

By Alan, on January 30th, 2023%

In a preclinical test, thyroid tissue earlier removed from lab animals was re-implanted in a protective pouch, which generates production of key hormones by the animals. . . . → Read More: Implanted Tissue Shown to Produce Thyroid Hormones

Grocery Chain Offering Sites for Cancer Biomarker Trial

By Alan, on January 25th, 2023%

The Kroger grocery store chain in the U.S. is establishing a clinical trial network through its urgent care centers, starting with a study of microbiome cancer biomarkers. . . . → Read More: Grocery Chain Offering Sites for Cancer Biomarker Trial

Nanotech Enzyme Process Boosts T-Cell Cancer Therapies

By Alan, on January 10th, 2023%

A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies

BioNTech to Provide Personal Cancer Immunotherapies in UK

By Alan, on January 6th, 2023%

The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030. . . . → Read More: BioNTech to Provide Personal Cancer Immunotherapies in UK

Biotech Alliance Creating Circular RNA Cancer Drug

By Alan, on January 5th, 2023%

A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment. . . . → Read More: Biotech Alliance Creating Circular RNA Cancer Drug

Protein Chemistry Biotech Gains Collaboration, Venture Funds

By Alan, on January 4th, 2023%

An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech. . . . → Read More: Protein Chemistry Biotech Gains Collaboration, Venture Funds

Peptide Discovery Company to Gain $3.3B in Licensing Deals

By Alan, on December 27th, 2022%

A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals

Infographic – Cancer Start-Up Venture Funds Decline

By Alan, on December 24th, 2022%

Chart: Venture funding for cancer start-ups, 2018-2022

Funding for new enterprises creating products and services that treat or detect cancer fell more than 40 percent from last year. . . . → Read More: Infographic – Cancer Start-Up Venture Funds Decline

Trial Shows Gel Clears Common Skin Cancer Wounds

By Alan, on December 19th, 2022%

Results of a clinical trial indicate a gel applied to lesions caused by basal cell carcinoma is safe for patients and clears the cancerous skin tumors. . . . → Read More: Trial Shows Gel Clears Common Skin Cancer Wounds

Trial Testing Ultrasound for Brain Cancer Liquid Biopsies

By Alan, on December 15th, 2022%

A clinical trial is underway testing the safety and feasibility of focused ultrasound to enable use of blood tests to monitor a patient’s glioblastoma, a form of brain cancer. . . . → Read More: Trial Testing Ultrasound for Brain Cancer Liquid Biopsies

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise